台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

賽諾菲股份有限公司 台北市信義區松仁路3號7樓 (97168356) - inactivated polio virus -type 1;;inactivated polio virus - type 2;;inactivated polio virus -type 3 - 滅菌懸液注射劑 - 主成分 (each 0.5mlcontain inactivated poliovirus) ; inactivated polio virus -type 1 (8012003100) (mahoney)40dag-u (antigenic unit); inactivated polio virus - type 2 (8012003200) (mef-1)8dag-u (antigenic unit); inactivated polio virus -type 3 (8012003300) (saukett)32dag-u (antigenic unit) - poliomyelitis, trivalent, inactivated, whole virus - 預防小兒麻痺症。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

荷商葛蘭素史克藥廠股份有限公司台灣分公司 台北市中正區忠孝西路一段66號23-24樓 (86927438) - a/victoria/4897/2022 (h1n1)pdm09-like strain (a/victoria/4897/2022, ivr-238);;a/darwin/9/2021 (h3n2) - like strain (a/darwin/6/2021, ivr-227);;b/austria/1359417/2021 - like strain (b/austria/1359417/2021, bvr-26);;b/phuket/3073/2013 - like strain (b/phuket/3073/2013, wild type) - 滅菌懸液注射劑 - a/victoria/4897/2022 (h1n1)pdm09-like strain (a/victoria/4897/2022, ivr-238) (8012002540) ug ha; b/phuket/3073/2013 - like strain (b/phuket/3073/2013, wild type) (8012006210) ug ha; b/austria/1359417/2021 - like strain (b/austria/1359417/2021, bvr-26) (8012006270) ug ha; a/darwin/9/2021 (h3n2) - like strain (a/darwin/6/2021, ivr-227) (8012018070) ug ha - influenza, inactivated, split virus or surface antigen - fluarix tetra是一種四價流感疫苗，適用於成人及6個月大以上之兒童的主動免疫接種，藉以預防此疫苗所涵蓋之a型與b型流感病毒所引起的流感相關疾病。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

中國化學製藥股份有限公司新豐工廠 新竹縣新豐鄉坑子口１８２之１號 (03088802) - dry vitamin e 50% type sd;;tocopherol acetate alpha dl- - 膜衣錠 - tocopherol acetate alpha dl- (8820000213) (50iu)mg; dry vitamin e 50% type sd (8820009800) mg - tocopherol (vit e) - 維生素e缺乏症

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

美商默沙東藥廠股份有限公司台灣分公司 台北市信義區信義路五段106號12樓 (86683720) - type 6 l1 protein;;type 11 l1 protein;;type 16 l1 protein;;type 18 l1 protein;;type 31 l1 protein;;type 33 l1 protein;;type 45 l1 protein;;type 52 l1 protein;;type 58 l1 protein - 滅菌懸液注射劑 - 主成分 (each syringe/vial) ; type 6 l1 protein (1600001610) ug; type 11 l1 protein (1600001620) ug; type 16 l1 protein (1600001630) ug; type 18 l1 protein (1600001640) ug; type 31 l1 protein (1600003100) ug; type 33 l1 protein (1600003200) ug; type 45 l1 protein (1600003300) ug; type 52 l1 protein (1600003400) ug; type 58 l1 protein (1600003500) ug - papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58) - gardasil 9適用於9至45歲的人施打，使其產生主動免疫反應，以預防下列由人類乳突病毒(hpv)所引起的病變：• 由 16, 18, 31, 33, 45, 52及 58型hpv所引起的子宮頸、外陰、陰道、肛門部位及口咽與其他頭頸部位的癌症• 由第6, 11, 16, 18, 31, 33, 45, 52及58型hpv 所引起的子宮頸、外陰、陰道及肛門部位的癌前病變• 由第6及11型 hpv所引起的生殖器疣(尖形濕疣)。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

賽諾菲股份有限公司 台北市信義區松仁路3號7樓 (97168356) - pertussis toxoid;;filamentous haemagglutinin;;agglutinogens fimbriae 2+3;;pertactin;;diphtheria toxoid;;tetanus toxoid;;inactivated poliovirus vaccine type i;;inactivated poliovirus vaccine type ii;;inactivated poliovirus vaccine type iii - 懸浮注射液 - pertussis toxoid (8004001620) mcg; diphtheria toxoid (8008000100) lf(units); tetanus toxoid (8008000200) lf(units); inactivated poliovirus vaccine type i (8012002201) d-antigen units; inactivated poliovirus vaccine type ii (8012002202) d-antigen units; inactivated poliovirus vaccine type iii (8012002203) d-antigen units; filamentous haemagglutinin (9200050300) mcg; agglutinogens fimbriae 2+3 (9200090400) mcg; pertactin (9900066600) mcg - vaccines - 適用於4歲(含)以上之兒童、青少年及成人，作為預防破傷風、白喉、百日咳及小兒麻痺的主動追加疫苗接種。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

賽諾菲股份有限公司 台北市信義區松仁路3號7樓 (97168356) - diphtheria toxoid;;tetanus toxoid;;pertussis bordetella;;pertussis toxoid;;filamentous haemagglutinin;;inactivated poliovirus vaccine type i;;inactivated poliovirus vaccine type ii;;inactivated poliovirus vaccine type iii;;hepatitis b, antigen, surface;;polysaccharide of haemophilus influenzae type b;;conjugated to the tetanus protein - 懸浮注射液 - pertussis toxoid (8004001620) ug; diphtheria toxoid (8008000100) diphtheria toxoid….……30lf (≧20iu)iu; tetanus toxoid (8008000200) tetanus toxoid..…………10lf (≧40iu)iu; conjugated to the tetanus protein (8008000230) 22-36μg; pertussis bordetella (8012000110) bordetella pertussis antigens; inactivated poliovirus vaccine type i (8012002201) (mahoney)du; inactivated poliovirus vaccine type ii (8012002202) (mef-1)du; inactivated poliovirus vaccine type iii (8012002203) (saukett)du; polysaccharide of haemophilus influenzae type b (8012020000) (polyribosylribitol phosphate)ug; hepatitis b, antigen, surface (8081211000) ug; filamentous haemagglutinin (9200050300) ug - diphtheria-haemophilus influenzae b-pertussis-poliomyelitis-tetanus-hepatitis b - 適用於出生6週以上之嬰兒及幼兒的基礎免疫接種和追加接種，以預防白喉、破傷風、百日咳、b型肝炎、小兒麻痺及b型嗜血桿菌(hib)所導致的侵襲性疾病。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

友華生技醫藥股份有限公司 臺北市北投區承德路６段128號13樓 (12397982) - botulinum toxin type a - 注射劑 - botulinum toxin type a (1220002600) u (unit) - botulinum toxin - 暫時性改善成人因皺眉肌(corrugator)和/或鼻眉肌(procerus)活躍而導致之中度至重度皺眉紋外觀表現。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

瑞士商艾伯維藥品有限公司台灣分公司 臺北市中山區民生東路3段49、51號15樓 (53653958) - botulinum toxin type a - 乾粉注射劑 - botulinum toxin type a (1220002600) u (unit) - botulinum toxin - 眼瞼痙攣、半面痙攣、局部肌肉痙攣、斜視、痙攣性斜頸、小兒腦性麻痺引起之肌肉痙攣、上臉部皺紋(皺眉紋、抬頭紋、魚尾紋)、原發性腋窩多汗症、成人上肢痙攣。因脊髓病變所引起的逼尿肌過動而導致尿失禁之成人病人，且經抗膽鹼類藥物治療無效或無法耐受者。治療有尿失禁、尿急與頻尿等膀胱過動症的成人病人，經抗膽鹼類藥物治療反應不佳或無法耐受必須停藥，且如有需要時，願意及能夠於治療後進行乾淨間歇性導尿(clean intermittent catheterization)者。適用於慢性偏頭痛(至少有3個月時間，每個月≥ 15天，每次持續4小時以上，且其中至少有一半的頭痛是偏頭痛)成人病人的頭痛預防性治療。(重要限制：botox對陣發性頭痛(每月頭痛天數≤14天)之安全性及有效性尚無證據證明。)治療成人病人之下肢痙攣，以減少踝關節和腳趾屈肌群(腓腸肌、比目魚肌、脛後肌、屈拇長肌和屈趾長肌)肌張力增加的嚴重程度。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

荷商葛蘭素史克藥廠股份有限公司台灣分公司 台北市中正區忠孝西路一段66號23-24樓 (86927438) - pertussis toxoid;;diphtheria toxoid;;tetanus toxoid;;pertactin;;filamentous haemagglutinin;;r-dna hepatitis b surface antigen adsorbed (hbsag);;inactivated polio virus -type 1;;inactivated polio virus - type 2;;inactivated polio virus -type 3;;conjugated of haemophilus influenzae type b capsular polysaccharide (prp) and tetanus toxoid (t), adsorbed - 凍晶注射劑 - pertussis toxoid (8004001620) ug; diphtheria toxoid (8008000100) i.u.; tetanus toxoid (8008000200) i.u.; inactivated polio virus -type 1 (8012003100) du; inactivated polio virus - type 2 (8012003200) du; inactivated polio virus -type 3 (8012003300) du; conjugated of haemophilus influenzae type b capsular polysaccharide (prp) and tetanus toxoid (t), adsorbed (8012004000) (10up of prp and 20-; r-dna hepatitis b surface antigen adsorbed (hbsag) (8081223400) ug; filamentous haemagglutinin (9200050300) ug; pertactin (9900066600) ug - diphtheria-haemophilus influenzae b-pertussis-poliomyelitis-tetanus-hepatitis b - infanrix hexa 適用於6週大以上之嬰兒及幼童的基礎免疫接種及追加接種，以對抗白喉、破傷風、百日咳、b型肝炎、小兒麻痺及b型嗜血桿菌。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

臺灣安萬特藥品股份有限公司 台北巿敦化南路一段１０８號９樓 (97168356) - isopropyl myristate - 原料藥溶液劑 - 主成分 (:nfxiv) ; isopropyl myristate (9600016200) - 潤滑劑